| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | LSD1/2-IN-4, a PCPA derivative, is an inhibitor oflysine-specific demethylase 1 (LSD1) and lysine-specific demethylase 2 (LSD2). LSD1/2-IN-4 inhibits LSD1 and LSD2 withKivalues of 0.11 μM and 130 μM, respectively. LSD1/2-IN-4 can be used for the research of several cancers including T-cell acute lymphoblastic leukemia (TALL)[1]. |
| IC50& Target | Ki: 0.11 μM (LSD1); 130 μM (LSD2)[1] |
| 体外研究 (In Vitro) | LSD1/2-IN-4 shows strong inhibitory activity against both LSD1 and LSD2 with Kivalues of 0.11 μM and 130 μM, respectively and not inhibits peroxidase with an IC50>500 μM[1]. |
| 分子量 | 248.07 |
| Formula | C9H8BrF2N |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
